See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.12▲ 1.22%
← KAR page
XStocksXray
Market X-Ray report · 27 October 2026

Karnov Group AB (KAR)

Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026

Key indicators

Last closeSEK 84.20
52-week range59.60 – 116.60
Return, 1 month / 3 months+14.6% / +20.1%
Return, 1 year / 3 years−24.4% / +77.3%
TrendUptrend
RSI (14)69
Volatility (1 year)44.2%
Worst drawdown (1 year)-45.3%
Average daily value traded12.41M SEK
Dividend yield–

Market X-Ray price-based

65/ 100 · High confidence · ahead of 70% of stocks on this exchange
Trend69
Momentum65
Stability (higher is calmer)51
Liquidity81
Income–

Five-year price chart navy: price · brown: 200-day average

34.9159.1383.351081322021-102023-012024-042025-072026-10

About the company

Karnov Group is a Swedish company that supplies legal, tax and regulatory information and software. It publishes searchable online collections of laws, court rulings and commentary, together with workflow tools that help users find and apply the rules. Its customers are mainly lawyers, courts, public authorities, companies and academic institutions, served largely in the Nordic countries and also in France and Spain. The company is based in Stockholm.

Karnov Group AB trades under the code KAR on the Nasdaq Stockholm in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Karnov Group AB (KAR) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 84.20 on 27 October 2026.

Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 270 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 24.4% and over the last three months it rose 20.1%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Karnov Group AB (KAR)

The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm

Lens and metricValueScoreReading
Trend69 · FairMixed trend against its averages.
Above 200-day average12.0%
From 52-week high-25.8%
Momentum65 · FairTypical recent returns for this exchange.
3-month return20.1%
6-month return21.5%
12-month return, skipping the last month-34.0%
Stability (higher is calmer)51 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)44.2%
Worst drawdown, 1 year (smaller is calmer)-45.3%
Liquidity81 · StrongTrades actively.
Average daily value traded12.41M SEK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

No lens is weak against its exchange.

Returns

1 week+4.2%
1 month+14.6%
3 months+20.1%
6 months+21.5%
1 year−24.4%
3 years+77.3%
5 years+51.2%

Signals

50-day / 200-day average78.29 / 75.20
Golden / death cross (60 days)Golden, 10 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.41

Technical summary

DailyStrongly bullish12 bullish · 1 neutral · 3 bearish
WeeklyStrongly bullish10 bullish · 1 neutral · 1 bearish
MonthlyNeutral4 bullish · 1 neutral · 3 bearish

Recent dividends

Ex-dividend dateAmount per share
6 May 2021SEK 1.0000
6 May 2020SEK 0.4500

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026